STUDY SUMMARY
Lung Cancer Model: TM00204
NSG™ mice engrafted with passage 3 tumors for model TM00204
were randomly assigned to one of these treatment groups:
- 0.5% carboxymethyl cellulose (CMC) (10 ml/kg; PO daily for 28 days; N=7)
- Erlotinib (50 mg/kg; PO daily for 28 days; N=7)
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups